OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Oncotelic Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026
- Market cap
- $8.66M
- P/E (TTM)
- 0.0
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 19, 2019(first seen in filings) | 1-for-5.5 reverse | Earlier per-share figures multiplied by 5.5 |
| Dec 28, 2012 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Dec 28, 2012 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Feb 23, 2011 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |